Connect with us

Community

Pfizer says they have millions of COVID-19 vaccine doses in their warehouse waiting for government direction

Published

on

New York, NY, December 17, 2020 –Pfizer Inc. Thursday night released the following statement to address public comments that allege there are issues in the production and distribution of the company’s COVID-19 vaccine:

“Pfizer is not having any production issues with our COVID-19 vaccine, and no shipments containing the vaccine are on hold or delayed. This week, we successfully shipped all 2.9 million doses that we were asked to ship by the U.S. Government to the locations specified by them. We have millions more doses sitting in our warehouse but, as of now, we have not received any shipment instructions for additional doses.

“We have continuously shared with Operation Warp Speed (OWS) and the U.S. Department of Health and Human Services through weekly meetings every aspect of our production and distribution capabilities. They have visited our facilities, walked the production lines and been updated on our production planning as information has become available.”

Pfizer stated that they have a successful and long track record of producing and distributing large volumes of complex vaccines that the world can trust –and are continuing to extend this track record with the COVID-19 vaccine.

“Over the last several months, we have activated Pfizer’s extensive manufacturing network, including thousands of highly skilled workers in multiple locations. As a result, Pfizer is manufacturing and readying for release millions of doses each day, and that volume will grow over the coming weeks. We remain confident in our ability to deliver up to 50 million doses globally this year and up to 1.3 billion next year, and we look forward to continuing to work with the US Government to deliver our vaccine to the American people.”

The Pfizer-BioNTech COVID-19 vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized for emergency use by FDA under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals 16 years of age and older.

Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Facebook

Copyright © 2017 Fall River Reporter

Translate »